Glykos Finland Oy

Suomen Punainen Risti Veripalvelu

Ulla Impola

Jari Natunen

Tero Satomaa

Annamari Heiskanen

Jarmo Laine

Heidi Anderson

Maria Blomqvist

Anne Olonen

Taina Jaatinen

Juhani Saarinen

Johanna Nystedt

Anita Laitinen

Milla Mikkola

Sari Tiitinen

Jukka Partanen

Sarl Tiitinen

Minna Tiittanen

The invention describes specific sialylated structures present on human stem cells and cell populations derived thereof. The invention is especially directed to methods to control the status of stem cells by observing changes in sialylation of the cells; and control of potential contaminations of biological materials; and reagents and methods used in connection with the cells in order to avoid alterations of the cell glycosylation by contaminating materials. The invention is further directed to novel stem cells, the glycosylation of which has been specifically altered.

Method for evaluating cell populations

The invention describes methods for production of novel composition of glycans, glycomes, from human multipotent stem cells. The invention is further directed to methods for modifying the glycomes and analysis of the glycomes and the modified glycomes. Furthermore the invention is directed to stem cells carrying the modified glycomes on their surfaces.

Carbohydrate profile compositions from human cells and methods for analysis and modification thereof

The invention relates to a method for culturing human embryonic stem cells (hESCs) and/or induced pluripotent stem (iPS) cells on a lectin. The invention relates also to the use of a lectin in a method for culturing human embryonic stem cells (hESCs) and/or induced pluripotent stem (iPS) celts and a culture medium composition containing a lectin attached on the culturing plates.

Culture of cells

Growing community of inventors

Helsinki, Finland

Ulla Impola